Days after the Oxford vaccine trial was halted due to suspected adverse reactions reported in a participant, on Wednesday, Mumbai's KEM Hospital officials said that the Drug Controller General of India (DCGI) has given them the green signal to resume the trials. Mumbai Khabar brings to you the top news of the day. Watch this video to know more!